Literature DB >> 14770266

Lack of generalizable evidence of the superiority of alfacalcidol over plain vitamin D in the treatment of glucocorticoid-induced osteoporosis: comment on the article by Ringe et al.

H Richard Barthel, Reinhold Vieth.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14770266     DOI： 10.1007/s00296-003-0436-7

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN： 0172-8172            Impact factor:   2.631


× No keyword cloud information.
  8 in total

Review 1.  [Benefits beyond the bones -- vitamin D against falls, cancer, hypertension and autoimmune diseases].

Authors:  H R Barthel; S H Scharla
Journal:  Dtsch Med Wochenschr       Date:  2003-02-28       Impact factor: 0.628

2.  Evidence that vitamin D3 increases serum 25-hydroxyvitamin D more efficiently than does vitamin D2.

Authors:  H M Trang; D E Cole; L A Rubin; A Pierratos; S Siu; R Vieth
Journal:  Am J Clin Nutr       Date:  1998-10       Impact factor: 7.045

3.  Efficacy and safety of vitamin D3 intake exceeding the lowest observed adverse effect level.

Authors:  R Vieth; P C Chan; G D MacFarlane
Journal:  Am J Clin Nutr       Date:  2001-02       Impact factor: 7.045

Review 4.  Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety.

Authors:  R Vieth
Journal:  Am J Clin Nutr       Date:  1999-05       Impact factor: 7.045

Review 5.  Calcium and vitamin D therapy in corticosteroid-induced bone loss: what is the evidence?

Authors:  J D Adachi; G Ioannidis
Journal:  Calcif Tissue Int       Date:  1999-10       Impact factor: 4.333

6.  Superiority of alfacalcidol over plain vitamin D in the treatment of glucocorticoid-induced osteoporosis.

Authors:  J D Ringe; A Dorst; H Faber; E Schacht; V W Rahlfs
Journal:  Rheumatol Int       Date:  2003-09-25       Impact factor: 2.631

Review 7.  Meta-analyses of therapies for postmenopausal osteoporosis. VIII: Meta-analysis of the efficacy of vitamin D treatment in preventing osteoporosis in postmenopausal women.

Authors:  Emmanuel Papadimitropoulos; George Wells; Beverley Shea; William Gillespie; Bruce Weaver; Nicole Zytaruk; Ann Cranney; Jonathan Adachi; Peter Tugwell; Robert Josse; Carol Greenwood; Gordon Guyatt
Journal:  Endocr Rev       Date:  2002-08       Impact factor: 19.871

8.  Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol.

Authors:  Robert P Heaney; K Michael Davies; Tai C Chen; Michael F Holick; M Janet Barger-Lux
Journal:  Am J Clin Nutr       Date:  2003-01       Impact factor: 7.045
  8 in total
  2 in total

1.  Questions on the superiority of alfacalcidol over plain vitamin D in the treatment of glucocorticoid-induced osteoporosis.

Authors:  Johann D Ringe
Journal:  Rheumatol Int       Date:  2004-10-13       Impact factor: 2.631

2.  [The mechanism of bone loss in rheumatoid arthritis. Description based on a case report].

Authors:  P Oelzner; F Buttgereit; W Demary; H Franck; P Kern; G Hein
Journal:  Z Rheumatol       Date:  2007-07       Impact factor: 1.372
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.